Frazier Lifesciences Acquisition Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by VIKING GLOBAL INVESTORS LP, was filed 04 Nov 2022.
Frazier Lifesciences Acquisition Corp: what insiders have been doing
Frazier Lifesciences Acquisition Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). Frazier Lifesciences Acquisition Corp has had no insider filing for more than a year; the last one goes back to 25 November 2022.
The full history, which starts in 2020, counts 3 purchases against no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended December 2021 · cache
- 1,211,582 sharesClass A Ordinary SharesSEC:0001140361-22-043107:1
- 2,459,880 sharesClass A Ordinary SharesSEC:0001140361-22-043107:0
- 279,530 shares@ US$10.0833.0% of flowCommon StockSEC:0001140361-22-040057:1Canonical exit: 31 Jan 2023 (T+90)
- 567,532 shares@ US$10.08100.0% of flowCommon StockSEC:0001140361-22-040057:0Canonical exit: 31 Jan 2023 (T+90)
- 501,000 shares@ US$10.0033.4% of flowClass A Ordinary SharesSEC:0001104659-20-134761:0
- 1,000,000 shares@ US$10.0066.6% of flowClass A Ordinary SharesSEC:0001104659-20-134761:1Canonical exit: 11 Mar 2021 (T+90)
6 of 6 declarations
About Frazier Lifesciences Acquisition Corp
Frazier Lifesciences Acquisition Corp is a special purpose acquisition company focused on the life sciences sector. It is listed on NASDAQ under the ticker XNAS.
